Individual.com logo
Welcome   (I'm not )
Select a date:

My Topics
Click here to add topics
Table bottom

My Companies
Click here to add companies
Table bottom

Newsdesks
Business
Finance
Internet
Computing
Environmental
Energy
Healthcare
Industry News, A-Z
Sports
Telecom
Transportation
Table bottom

Search
Google News
Table bottom

My Settings
Topics
Companies
Personal Info
Preferences
Forgot Password?
Log out
Table bottom

Top Topics
No top stories
Table bottom

Top Topics
Financial Services & Investing
Stock Market
Alternative Energy
Aerospace & Defense
Telecom News
Government
Managed Health Care
Natural Disaster
Economic Indicators
Internet Media, Content & Design
Table bottom

Pharmaceuticals & Drug Approval
Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospitals and other acute care settings, today announced the publication of new intravenous (IV) meloxicam data. The article,...
GlobeNewswire, 7:08am ET



Indivior PLC (LON: INDV) today announced that its U.S. affiliate, Indivior Inc., has launched an authorized generic version of SUBOXONE(R) (buprenorphine and naloxone) Sublingual Film (CIII) in the U.S. The authorized generic is being marketed...
PR Newswire Europe, 9:58am ET

Indivior PLC (LON: INDV) today announced that its U.S. affiliate, Indivior Inc., has launched an authorized generic version of SUBOXONE® (buprenorphine and naloxone) Sublingual Film (CIII) in the U.S. The authorized generic is being marketed and...
PR Newswire, 9:43am ET

Adelaide, Australia, Feb. 19 -- Mayne Pharma issued the following news release: Mayne Pharma Group Limited (ASX: MYX) is pleased to announce that the Therapeutic Goods Administration (TGA) has approved KAPANOL low dose sustained-release...
Contify, 9:09am ET

Glen Rock, New Jersey, Feb. 19 -- RespireRX Pharmaceuticals Inc. issued the following news release: RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) ("RespireRx" or the "Company"), a leader in the research and development of cannabinoids for...
Contify, 9:09am ET

via NEWMEDIAWIRE -- CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering Cardiol Therapeutics (TSX: CRDL) (OTC: CRTPF) and...
GlobeNewswire, 9:08am ET

Cerevel Therapeutics, a biopharmaceutical company focused on developing new medicines to treat disorders of the central nervous system (CNS), today announced that it has appointed veteran CNS medicines developer Raymond...
BusinessWire, 8:08am ET

-- 58% treatment benefit seen versus active comparator in Phase 2B for planned Phase 3 target population -- Gencaro development program has FDA Fast Track designation -- U.S. and European cardiovascular patents and regulations...
GlobeNewswire, 7:43am ET

Pharmaceutical Product Development, LLC (PPD) and Happy Life Tech (HLT) of China have signed an exclusive agreement to develop a distinctive service offering for the China drug-development market delivering data...
BusinessWire, 7:08am ET

JERUSALEM , Feb. 19 -- Intec Pharma issued the following news release: - AP-CD/LD met primary endpoint of reducing plasma levodopa variability compared to standard oral CD/LD with statistical significance Intec Pharma Ltd. (NASDAQ:...
Contify, 9:09am ET

BURLINGTON, North Carolina, Feb. 19 -- Laboratory Corporation of America(R) Holdings issued the following news release: - LabCorp's DoseASSURE Portfolio Provides Most Expansive Biologics TDM Menu Combined with Expert Guidance...
Contify, 9:09am ET

Madrid, Guangzhou, Feb. 18 -- PharmaMar issued the following news release: The companies Genomica (Madrid, Spain) and HuaSin (Guangzhou, China), announced to join forces in an attempt to address the globally rising challenge of early...
Contify, 8:48am ET

Based in Shirley, New York, one of the world’s leading peptide suppliers Creative Peptides announced to launch its pharmaceutical peptides services on February 19, 2019, extending the application of peptides into pharmaceutical research...
ABNewswire, 9:13am ET

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL;ADILW) www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development of medicines for addiction, today announced a partnership with Catalent Pharma Solutions, a leading global...
GlobeNewswire, 9:09am ET

Malvern, Pennsylvania, Feb. 19 -- Recro Pharma Inc issued the following news release: Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care...
Contify, 9:08am ET

SAN DIEGO, California, Feb. 19 -- ARS Pharmaceuticals, Inc. issued the following news release: ARS Pharmaceuticals, Inc., a pharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from...
Contify, 9:03am ET

According to Market Research Future (MRFR)’s analysis, the global regenerative medicine market is prognosticated to mark an exponential CAGR of 25.4% during the forecast period 2016 to 2022. The popularity of regenerative medicine is...
ABNewswire, 6:38am ET

GRAND RAPIDS, Michigan, Feb. 19 -- Meijer issued the following news release: - Retailer installs secure, in-store kiosks for customers to safely dispose of unused or expired medications Meijer announced today it is launching its new...
Contify, 9:18am ET

OAKLAND, California, Feb. 19 -- Modis Therapeutics issued the following news release: - Designation Based on Compelling Data from Initial Clinical Studies and High Unmet Need in Thymidine Kinase 2 Deficiency Modis Therapeutics...
Contify, 9:09am ET

IRVINE, California, Feb. 19 -- Novus Therapeutics issued the following news release: Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose,...
Contify, 9:09am ET

1-20 of 628
Next 20 >>


Tell a Friend About Us

Home Help My Settings Privacy Policy Terms of Service Advertising About Us Contact Us Logout

Copyright 1995-, Individual.com. No redistribution allowed.